Guided Therapeutics (GTHP) Receivables (2010 - 2025)
Guided Therapeutics (GTHP) reported Receivables of $4000.0 for Q4 2025, up 33.33% on a YoY basis from $3000.0 in Q4 2024, and down 33.33% sequentially from $6000.0 in Q3 2025.
Guided Therapeutics (GTHP) Receivables (2010 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 16 years of Receivables data on file, last reported at $4000.0 in Q4 2025.
- For the quarter ending Q4 2025, Receivables rose 33.33% year-over-year to $4000.0; the trailing twelve-month figure through Dec 2025 stood at $4000.0 (up 33.33% YoY), and the FY2025 full-year result was $4000.0, up 33.33% from the prior year.
- Receivables fell to $4000.0 in Q4 2025, from $6000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $502.0 million in Q2 2021 to a low of $2000.0 in Q1 2025.
- A 5-year average of $41.0 million and a median of $8942.0 in 2023 frame the typical range for Receivables.
- Across the five-year window, Receivables soared 401500.0% in 2021 and sank 99.97% in 2023, its largest moves.
- Tracing GTHP's Receivables over 5 years: stood at $126000.0 in 2021, then climbed by 3.96% to $130984.0 in 2022, then slumped by 94.66% to $7000.0 in 2023, then slumped by 57.14% to $3000.0 in 2024, then jumped by 33.33% to $4000.0 in 2025.
- Business Quant data shows GTHP's Receivables at $4000.0 in Q4 2025, $6000.0 in Q3 2025, and $8000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.11 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.80 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.55 Bn |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 2,047.00 |
| Jun 30, 2024 | 2,047.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 8,942.00 |
| Jun 30, 2023 | 8,942.00 |
| Mar 31, 2023 | 55,314.00 |
| Dec 31, 2022 | 130,984.00 |
| Sep 30, 2022 | 120,691.00 |
| Jun 30, 2022 | 179,831.00 |
| Mar 31, 2022 | 165.13 Mn |
| Dec 31, 2021 | 126,000.00 |
| Sep 30, 2021 | 149.00 Mn |
| Jun 30, 2021 | 502.00 Mn |
| Mar 31, 2021 | 3.51 Mn |